Seeing Machines forms eye disease master pact with Australian National University:
This article was originally published in Clinica
Executive Summary
Canberra, Australia-based Seeing Machines has signed a master development and commercialisation deal with the Australian National University (ANU) to develop diagnostics for eye diseases, such as glaucoma. Under the agreement, computer vision systems maker Seeing Machines will provide the university, also based in Canberra, with equipment, software and know-how, including non-commercialised proprietary technologies. In return, the company has first rights to exclusively commercialise any new IP developed under the pact. The company and the ANU have already teamed up on the development of the company's TrueField Analyzer, for helping doctors diagnose and manage a range of eye diseases, including glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy. The device has yet to reach the market.